Lataa...
Clinical trial endpoints for patients with gliomas
Malignant glioma represents a diverse set of molecularly heterogeneous diseases. Few therapeutic agents have been approved despite decades of clinical trials research and pre-clinical investigation. Attempts to refine neuroimaging criteria and recent discovery of the genomic profiles linking tumor s...
Tallennettuna:
| Julkaisussa: | Neurooncol Pract |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655446/ https://ncbi.nlm.nih.gov/pubmed/31385993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npw034 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|